Who is sponsoring NCT03461562?

NCT03461562 is sponsored by Okan University.

What drugs are being tested in NCT03461562?

Interventions in NCT03461562: Aerobic Exercise.

What condition does NCT03461562 study?

NCT03461562 studies Nonalcoholic Fatty Liver Disease.

Is NCT03461562 still recruiting?

NCT03461562 is currently completed. Last updated 6 August 2018.

Last reviewed 2018-08-06 · How we verify

NCT03461562

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLD

Completed NA Last updated 6 August 2018

What this trial tests

NA trial testing Aerobic Exercise in Nonalcoholic Fatty Liver Disease in 31 participants. Completed in 1 August 2018.

Timeline

5 January 2018

Primary endpoint
30 June 2018

1 August 2018

Quick facts

Lead sponsor	Okan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	31
Start date	5 January 2018
Primary completion	30 June 2018
Estimated completion	1 August 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Aerobic Exercise — full drug profile →

Conditions studied

Nonalcoholic Fatty Liver Disease — all drugs for Nonalcoholic Fatty Liver Disease →

Sponsor

Okan University

Who can join

Adults 18 to 65, any sex, with Nonalcoholic Fatty Liver Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose of the study will investigate the effects of two different training programs on hepatic steatosis and physical fitness parameters. This trial is designed in a randomized controlled study plan and aerobic training (40 minutes) wil be combined with Whole Body Vibration Training (WBVT for 15 minutes) which is made up of a shorter time application. WBVT to be applied instead of the resistance exercises.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.
Buzzetti E, Linden A, Best LM, Madden AM, et al · · 2021 · cited 28× · PMID 34114650 · DOI 10.1002/14651858.cd013156.pub2

Verify or expand the search:

Other trials of Aerobic Exercise

Trials testing the same drug.

NCT07517224 — Assessing the Effect of an Aerobic Exercise Program on Vascular Function in Women With Non-Metastatic Breast Cancer · NA · not yet recruiting
NCT07444333 — Cardiac Output and Fatigue in Friedreich's Ataxia · NA · not yet recruiting
NCT07182006 — Exercise as Medicine for Pediatric Chronic Pain · NA · not yet recruiting
NCT07404319 — Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant · NA · not yet recruiting
NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting

Other recruiting trials for Nonalcoholic Fatty Liver Disease

Currently open trials in the same condition.

NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07093346 — The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patient · NA · recruiting
NCT07248371 — Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases · recruiting
NCT07149571 — To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status · recruiting
NCT06368882 — Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty · Phase 4 · recruiting

Other Okan University trials

Trials by the same sponsor.

NCT07457034 — Digital Follow-Up and Nursing Education in Bariatric Surgery Patients · NA · not yet recruiting
NCT07457905 — THE RELATIONSHIP BETWEEN PAIN ANXIETY AND POST-OPERATIVE PAIN IN PATIENTS UNDERGOING CHOLECYSTECTOMY SURGERY · not yet recruiting
NCT07462832 — Effect of Connective Tissue Massage in Low Back Pain · NA · not yet recruiting
NCT07408401 — Exercise Program Combined With Ergonomic Training in Textile Workers · NA · not yet recruiting
NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03461562 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Okan University
Last refreshed: 6 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03461562.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing